Lv2
106 积分 2024-02-22 加入
Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies
1个月前
已完结
Development of CAR T cells designed to improve antitumor efficacy and safety
1个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
1个月前
已完结
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
1个月前
已完结
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors
2个月前
已完结
CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl
2个月前
已关闭
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
2个月前
已关闭
Universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia
3个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
3个月前
已完结
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
3个月前
已关闭
皖公网安备34019202002308
